The first level is a written appeal submitted by mail, fax, or through the Sydney Health portal
Frequency recommendations typically range from once to twice weekly
Sources MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (May 11, 2025)
For those who qualify, TrimRX provides customized weight loss plans that incorporate GLP-1 medications such as semaglutide or tirzepatide
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide first identified in the 1970s during studies on sleep regulation in rabbits
[PMID: 10746931] PubMed record related to this compound for laboratory literature review